This inventor holds 4 USPTO granted patents and 1 published patent application. Top assignees: Boehringer Mannheim Gmbh, Winfried Albert, Other. Active years: 1992-2003.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Location History:
- Tutzing, DE (1992)
- Bernried, DE (1997 - 2003)
Company Filing History:
2 out of 1,164 
1 out of 1 
1 out of 834,513 Years Active: 1992-2003
Title: Heinrich Barchet: Innovator in Tumor Therapy
Introduction
Heinrich Barchet is a notable inventor based in Bernried, Germany. He has made significant contributions to the field of immunology, particularly in the development of therapeutic agents for tumor therapy. With a total of 4 patents, Barchet's work has the potential to impact cancer treatment significantly.
Latest Patents
One of Barchet's latest patents involves the creation of tumoricidal T lymphocytes. This invention concerns a mammalian cell line that, when co-cultured with lymphocytes while avoiding allogenic stimulation, activates lymphocytes to form tumoricidal cells. The process includes the production of these tumoricidal T lymphocytes and their use in developing therapeutic agents for tumor therapy. Another significant patent focuses on a method for producing and multiplying lymphocytes in cell culture medium. This method utilizes lymphocyte growth factors along with aurin tricarboxylic acid, ciclosporin, tacrolimus, and/or ascomycin.
Career Highlights
Throughout his career, Heinrich Barchet has worked with various organizations, including Boehringer Mannheim GmbH. His innovative approaches have led to advancements in the field of cell therapy and immunology.
Collaborations
Barchet has collaborated with notable individuals in his field, including Herbert Jungfer and Winfried Albert. These partnerships have contributed to the development of his groundbreaking inventions.
Conclusion
Heinrich Barchet's contributions to tumor therapy through his innovative patents highlight his role as a significant figure in the field of immunology. His work continues to pave the way for advancements in cancer treatment.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile